Results 131 to 140 of about 2,539,381 (235)

Open-access publishing in times of crises: The future of scientific success lies in accessibility for all

Marshall Journal of Medicine, 2021
Darshana Shah
doaj   +1 more source

The VHL tumor suppressor at the crossroad of protein folding, aggregation, and cancer

Molecular Oncology, EarlyView.
Mutations, environmental stress, and chaperone dysfunction can destabilize pVHL, promoting its conversion from the native folded state into amyloid‐like assemblies. This transition may contribute to protein storage, cell dormancy, survival, and drug resistance.
Lara Abad, Silvio Carlo Ermanno Tosatto, Emanuela Leonardi   +2 more
wiley   +1 more source

Variability in article processing charges of open-access publishing across medical specialties. [PDF]

PLoS One
Tocco EG, Mayhew MM, Mercante MG, Kuchimanchi N, Moheb ME, Shen C, Tsung A, Witt RG.   +7 more
europepmc   +1 more source

Celebrating 20 years of open access publishing at BMC Musculoskeletal Disorders. [PDF]

BMC Musculoskelet Disord, 2020
Fitzpatrick CM, Athwal A.
europepmc   +1 more source

Extracellular vesicle lipidomics liquid biopsy reveals systemic and tumor microenvironment metabolic reprogramming in ovarian cancer

Molecular Oncology, EarlyView.
Extracellular vesicle (EV) lipidomic profiling of plasma and ascites from patients with high‐grade serous ovarian cancer and of ovarian cancer cell lines reveals enrichment of triglycerides (TGs), diacylglycerols (DGs), phosphatidylcholine (PCs), sphingomyelins (SMs), reflecting tumor metabolic reprogramming.
Shikha Rani, Dominic Guanzon, Andrew Lai, Katherin Scholz‐Romero, Sarah Reed, Edita Ritmejeryte, Rohan Lourie, Naven Chetty, Kaltin Ferguson, Carlos Salomon   +9 more
wiley   +1 more source

Hurdles to open access publishing faced by authors: a scoping literature review from 2004 to 2023. [PDF]

R Soc Open Sci
Kaliuzhna N, Aydin Z, Müller P, Hauschke C.   +3 more
europepmc   +1 more source

Project DEAL - Germany is leading the way in the transition to open access publishing. [PDF]

J Appl Clin Med Phys, 2020
Mills M.
europepmc   +1 more source

Predictive and prognostic biomarkers of Bacillus Calmette‐Guérin therapy failure in bladder cancer patients: A systematic review

Molecular Oncology, EarlyView.
High‐risk bladder cancer is typically treated with Bacillus Calmette‐Guérin (BCG), but 30–40% of patients relapse. No FDA‐ or CE‐approved biomarkers currently predict or prognosticate BCG failure. We systematically reviewed the literature and identified 72 eligible studies, revealing several promising biomarkers associated with BCG treatment response ...
Rui Ribeiro‐Pereira, Ana Teixeira‐Marques, Rui Freitas, João A Carvalho, Sara Monteiro‐Reis, Giorgio I. Russo, Rui Henrique, Carmen Jerónimo   +7 more
wiley   +1 more source

Economic and geographical disparities in global contribution to open access publishing in anaesthesiology: A bibliometric analysis. [PDF]

Indian J Anaesth
Slawka E, Guerra-Londono JJ, Hicklen RS, Solanki SL, Cukierman D, Tian J, Cata JP.   +6 more
europepmc   +1 more source

Publishing at any cost: a cross-sectional study of the amount that medical researchers spend on open access publishing each year. [PDF]

BMJ Open, 2021
Ellingson MK, Shi X, Skydel JJ, Nyhan K, Lehman R, Ross JS, Wallach JD.   +6 more
europepmc   +1 more source